Please enable JavaScript to continue using this application.

Compare $ARMP vs $AVXL | Chartloom

Compare

$ARMP vs $AVXL

Armata Pharmaceuticals Inc · Anavex Life Sciences Corp

ARMP

Armata Pharmaceuticals Inc

AVXL

Anavex Life Sciences Corp

Compare $ARMP vs $AVXL

Comparing Armata Pharmaceuticals Inc and Anavex Life Sciences Corp

ARMPArmata Pharmaceuticals Inc

AVXLAnavex Life Sciences Corp

ARMPArmata Pharmaceuticals Inc

Market cap

$133M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.3%

YTD performance

-44.7%

52W performance

12.7%

FCF yield

-19.4%

AVXLAnavex Life Sciences Corp

Market cap

$138M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-59.5%

52W performance

-84.9%

FCF yield

-21.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARMP

AVXL

Detailed metrics comparison

ARMP

Armata Pharmaceuticals Inc

AVXL

Anavex Life Sciences Corp

Market Cap

ARMP$133M

AVXL$138M

Enterprise Value

ARMP$393M

AVXL$20M

Price

ARMP$3.63

AVXL$1.49

P/E Ratio

ARMPN/A

AVXLN/A

P/S Ratio

ARMP24.04x

AVXL0.00x

EV/Sales

ARMP70.87x

AVXL0.00x

EV/EBITDA

ARMP0.00x

AVXL0.00x

P/B Ratio

ARMP6.85x

AVXL1.50x

P/FCF Ratio

ARMPN/A

AVXLN/A

EV/FCF

ARMP-15.23x

AVXL-0.67x

PEG Ratio

ARMPN/A

AVXLN/A

Forward P/E (NTM)

ARMPN/A

AVXLN/A

Forward P/S (NTM)

ARMPN/A

AVXLN/A

Revenue (TTM)

ARMP$6M

AVXL$0

Revenue Growth (YoY)

ARMP-19.3%

AVXLN/A

Forward Rev Growth

ARMP-35.3%

AVXL377.5%

Gross Margin (TTM)

ARMP0.0%

AVXL0.0%

Operating Margin (TTM)

ARMP0.0%

AVXL0.0%

EBITDA Margin (TTM)

ARMP-603.4%

AVXL0.0%

Net Margin (TTM)

ARMP-3467.0%

AVXL0.0%

FCF Margin (TTM)

ARMP-465.3%

AVXLN/A

Net Income (TTM)

ARMP$-192M

AVXL$-13M

FCF (TTM)

ARMP$-26M

AVXL$-29M

EPS (TTM)

ARMP-$3.10

AVXL-$0.14

ROE (TTM)

ARMP-12000.0%

AVXL-1143.0%

ROA (TTM)

ARMP-23569.0%

AVXL-1072.0%

ROIC (TTM)

ARMP-8123.0%

AVXL-1143.0%

Cash

ARMP$24M

AVXL$118M

Debt

ARMP$284M

AVXL$0

Net Cash/Debt

ARMP$-260M

AVXL$118M

Current Ratio (TTM)

ARMP0.11x

AVXL15.62x

Quick Ratio (TTM)

ARMP0.11x

AVXL15.51x

Debt/Equity (TTM)

ARMP1.38x

AVXL0.00x

Debt/Assets (TTM)

ARMP0.0%

AVXL0.0%

Interest Coverage (TTM)

ARMPN/A

AVXLN/A

Net Debt/EBITDA (TTM)

ARMP0.00x

AVXL0.00x

Beta

ARMP1.66

AVXL1.20

52W Performance

ARMP12.7%

AVXL-84.9%

YTD Performance

ARMP-44.7%

AVXL-59.5%

% from 52W High

ARMP-77.8%

AVXL-85.0%

% from 52W Low

ARMP17.5%

AVXL3.5%

Asset Turnover (TTM)

ARMP0.07x

AVXL0.00x

FCF Yield (TTM)

ARMP-19.4%

AVXL-21.2%

Earnings Yield (TTM)

ARMP-144.2%

AVXL-9.4%

Dividend Yield (TTM)

ARMPN/A

AVXLN/A

Rule of 40

ARMP-484.6

AVXL0.0

EV/GP/RG

ARMPN/A

AVXLN/A

Ticker research

View ARMP research View AVXL research

Metric	ARMP Armata Pharmaceuticals Inc	AVXL Anavex Life Sciences Corp
Market & Valuation
Market Cap	$133M	$138M
Enterprise Value	$393M	$20M
Price	$3.63	$1.49
P/E Ratio	N/A	N/A
P/S Ratio	24.04x	0.00x
EV/Sales	70.87x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.85x	1.50x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.23x	-0.67x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	-19.3%	N/A
Forward Rev Growth	-35.3%	377.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-603.4%	0.0%
Net Margin (TTM)	-3467.0%	0.0%
FCF Margin (TTM)	-465.3%	N/A
Net Income (TTM)	$-192M	$-13M
FCF (TTM)	$-26M	$-29M
EPS (TTM)	-$3.10	-$0.14
ROE (TTM)	-12000.0%	-1143.0%
ROA (TTM)	-23569.0%	-1072.0%
ROIC (TTM)	-8123.0%	-1143.0%
Financial Health
Cash	$24M	$118M
Debt	$284M	$0
Net Cash/Debt	$-260M	$118M
Current Ratio (TTM)	0.11x	15.62x
Quick Ratio (TTM)	0.11x	15.51x
Debt/Equity (TTM)	1.38x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	1.20
52W Performance	12.7%	-84.9%
YTD Performance	-44.7%	-59.5%
% from 52W High	-77.8%	-85.0%
% from 52W Low	17.5%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.00x
FCF Yield (TTM)	-19.4%	-21.2%
Earnings Yield (TTM)	-144.2%	-9.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-484.6	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ARMP research	View AVXL research

Valuation

P/S Ratio

AVXL

0.00x

ARMP

24.04x

EV/FCF

ARMP

-15.23x

AVXL

-0.67x

Growth & revenue

Revenue Growth TTM

ARMP

-19.3%

Forward Revenue Growth

AVXL

377.5%

ARMP

-35.3%

Profitability & performance

Gross Margin

ARMP

0.0%

AVXL

0.0%

ROE

AVXL

-1143.0%

ARMP

-12000.0%

FCF Yield %

ARMP

-19.4%

AVXL

-21.2%

52-Week Performance

ARMP

12.7%

AVXL

-84.9%

Detailed metrics comparison

ARMP

Armata Pharmaceuticals Inc

AVXL

Anavex Life Sciences Corp

Market Cap

ARMP$133M

AVXL$138M

Enterprise Value

ARMP$393M

AVXL$20M

Price

ARMP$3.63

AVXL$1.49

P/E Ratio

ARMPN/A

AVXLN/A

P/S Ratio

ARMP24.04x

AVXL0.00x

EV/Sales

ARMP70.87x

AVXL0.00x

EV/EBITDA

ARMP0.00x

AVXL0.00x

P/B Ratio

ARMP6.85x

AVXL1.50x

P/FCF Ratio

ARMPN/A

AVXLN/A

EV/FCF

ARMP-15.23x

AVXL-0.67x

PEG Ratio

ARMPN/A

AVXLN/A

Forward P/E (NTM)

ARMPN/A

AVXLN/A

Forward P/S (NTM)

ARMPN/A

AVXLN/A

Revenue (TTM)

ARMP$6M

AVXL$0

Revenue Growth (YoY)

ARMP-19.3%

AVXLN/A

Forward Rev Growth

ARMP-35.3%

AVXL377.5%

Gross Margin (TTM)

ARMP0.0%

AVXL0.0%

Operating Margin (TTM)

ARMP0.0%

AVXL0.0%

EBITDA Margin (TTM)

ARMP-603.4%

AVXL0.0%

Net Margin (TTM)

ARMP-3467.0%

AVXL0.0%

FCF Margin (TTM)

ARMP-465.3%

AVXLN/A

Net Income (TTM)

ARMP$-192M

AVXL$-13M

FCF (TTM)

ARMP$-26M

AVXL$-29M

EPS (TTM)

ARMP-$3.10

AVXL-$0.14

ROE (TTM)

ARMP-12000.0%

AVXL-1143.0%

ROA (TTM)

ARMP-23569.0%

AVXL-1072.0%

ROIC (TTM)

ARMP-8123.0%

AVXL-1143.0%

Cash

ARMP$24M

AVXL$118M

Debt

ARMP$284M

AVXL$0

Net Cash/Debt

ARMP$-260M

AVXL$118M

Current Ratio (TTM)

ARMP0.11x

AVXL15.62x

Quick Ratio (TTM)

ARMP0.11x

AVXL15.51x

Debt/Equity (TTM)

ARMP1.38x

AVXL0.00x

Debt/Assets (TTM)

ARMP0.0%

AVXL0.0%

Interest Coverage (TTM)

ARMPN/A

AVXLN/A

Net Debt/EBITDA (TTM)

ARMP0.00x

AVXL0.00x

Beta

ARMP1.66

AVXL1.20

52W Performance

ARMP12.7%

AVXL-84.9%

YTD Performance

ARMP-44.7%

AVXL-59.5%

% from 52W High

ARMP-77.8%

AVXL-85.0%

% from 52W Low

ARMP17.5%

AVXL3.5%

Asset Turnover (TTM)

ARMP0.07x

AVXL0.00x

FCF Yield (TTM)

ARMP-19.4%

AVXL-21.2%

Earnings Yield (TTM)

ARMP-144.2%

AVXL-9.4%

Dividend Yield (TTM)

ARMPN/A

AVXLN/A

Rule of 40

ARMP-484.6

AVXL0.0

EV/GP/RG

ARMPN/A

AVXLN/A

Ticker research

View ARMP research View AVXL research

Metric	ARMP Armata Pharmaceuticals Inc	AVXL Anavex Life Sciences Corp
Market & Valuation
Market Cap	$133M	$138M
Enterprise Value	$393M	$20M
Price	$3.63	$1.49
P/E Ratio	N/A	N/A
P/S Ratio	24.04x	0.00x
EV/Sales	70.87x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.85x	1.50x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.23x	-0.67x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	-19.3%	N/A
Forward Rev Growth	-35.3%	377.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-603.4%	0.0%
Net Margin (TTM)	-3467.0%	0.0%
FCF Margin (TTM)	-465.3%	N/A
Net Income (TTM)	$-192M	$-13M
FCF (TTM)	$-26M	$-29M
EPS (TTM)	-$3.10	-$0.14
ROE (TTM)	-12000.0%	-1143.0%
ROA (TTM)	-23569.0%	-1072.0%
ROIC (TTM)	-8123.0%	-1143.0%
Financial Health
Cash	$24M	$118M
Debt	$284M	$0
Net Cash/Debt	$-260M	$118M
Current Ratio (TTM)	0.11x	15.62x
Quick Ratio (TTM)	0.11x	15.51x
Debt/Equity (TTM)	1.38x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	1.20
52W Performance	12.7%	-84.9%
YTD Performance	-44.7%	-59.5%
% from 52W High	-77.8%	-85.0%
% from 52W Low	17.5%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.00x
FCF Yield (TTM)	-19.4%	-21.2%
Earnings Yield (TTM)	-144.2%	-9.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-484.6	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ARMP research	View AVXL research